Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism

Journal:

The EMBO Journal

Published:

2026-04-22

DOI:

10.1038/s44318-026-00776-2

Affiliations:

6

Authors:

11

Go to article

Institutions	Authors	Share
Cleveland Clinic, United States of America (USA)	5.000000	0.45
Vanderbilt University (VU), United States of America (USA)	3.000000	0.27
Weill Cornell Medicine, United States of America (USA)	2.000000	0.18
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM), United States of America (USA)	1.000000	0.09

Interested in Oncology and Carcinogenesis?